ID
14171
Description
Omacetaxine Mepesuccinate, Cytarabine, and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT02029417
Link
https://clinicaltrials.gov/show/NCT02029417
Keywords
Versions (1)
- 4/2/16 4/2/16 -
Uploaded on
April 2, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome NCT02029417
Eligibility Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome NCT02029417
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Acute Promyelocytic Leukemia
Data type
boolean
Alias
- UMLS CUI [1]
- C0023487
Description
Protocol Compliance
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0525058
- UMLS CUI [1,2]
- C0009488
Description
Non-Compliance With Study Drug
Data type
boolean
Alias
- UMLS CUI [1]
- C1709261
Description
Sickle cell SC disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0853729
Description
Investigational New Drugs
Data type
boolean
Alias
- UMLS CUI [1]
- C0013230
Description
Communicable Diseases
Data type
boolean
Alias
- UMLS CUI [1]
- C0009450
Similar models
Eligibility Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome NCT02029417
C0009488 (UMLS CUI [1,2])